RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Erica Cassimere to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Erica Cassimere has written about Protein Kinase Inhibitors.
Erica Cassimere
Connection Strength
0.167
Protein Kinase Inhibitors
  1. Folk WP, Kumari A, Iwasaki T, Cassimere EK, Pyndiah S, Martin E, Homlar K, Sakamuro D. New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors. Int J Mol Sci. 2021 Dec 11; 22(24).
    View in: PubMed
    Score: 0.167
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support